Hap Trading, LLC Brainstorm Cell Therapeutics Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$1.37 - $4.42 $14,248 - $45,968	10,400 New	10,400 $2,000
Q4 2020 Feb 16, 2021	SELL	$3.99 - $17.73 $258,951 - $1.15 Million	-64,900 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$11.19 - $16.92 $308,844 - $466,992	27,600 Added 73.99%	64,900 $603,000
Q2 2020 Aug 10, 2020	BUY	$4.42 - $12.66 $7,956 - $22,788	1,800 Added 5.07%	37,300 $114,000
Q1 2020 May 08, 2020	BUY	$4.01 - $8.88 $101,854 - $225,552	25,400 Added 251.49%	35,500 $19,000
Q4 2019 Feb 11, 2020	BUY	$3.62 - $4.29 $36,562 - $43,329	10,100 New	10,100 $3,000

10.6M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $73.7M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.